Is It Still Worth Buying GSK After a 46% Rally in Shares This Year
GSK has seen a steep run in its stock, prompting questions about whether the rally still offers upside. This article ...
Compares the volatility characteristics of risk parity against index funds in retirement planning, highlighting stability and risk exposure.
27,630 articlesGSK has seen a steep run in its stock, prompting questions about whether the rally still offers upside. This article ...
UK tax authorities plan to buy crypto forensic tools to pursue digital asset tax fraud. The move signals a broader pu...
A small exodus of California's billionaires ahead of a proposed wealth tax could erase billions in expected revenue. ...
Netflix charts a high-stakes path, slowing buybacks to fund a debt-heavy growth plan and weighing a marquee deal, as ...
A growing cadre of traders argues XRP could hit $10 even as it trades around $1.42, sparking a debate about what a pr...
A former antitrust prosecutor who helped litigate the JetBlue-Spirit merger shares lessons for future airline regulat...
Steris (STE) offers a steady earnings narrative in a healthcare environment shaped by infection control needs. This a...
A Nvidia-backed AI infrastructure player is quietly reshaping how enterprises train and run AI. This piece breaks dow...
Public trading disclosures show a sharp spike in activity by the former president, with Trump’s trading volume just s...
Adobe faces a pivotal shift as its own AI tool accelerates cannibalization of the stock library, forcing a rethinking...
In a shock move, TapTools announced it will wind down operations within 14 days after a wave of leadership departures...
Analysts warn that the global airline industry’s profits are set to fall sharply in 2026 as fuel bills rise and fligh...